Verrieres le Buisson, France

Phillip Manoury

This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip Manoury. Retrieved from https://idiyas.com/inventor/phillip-manoury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Profile: Phillip Manoury

Introduction

Phillip Manoury is a prominent inventor based in Verrières-le-Buisson, France. His contribution to the field of medicinal chemistry is noteworthy, specifically his work on innovative compounds that hold promise for therapeutic applications.

Latest Patents

Manoury holds one patent for his invention titled "1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives." The patent details compounds of a specific formula where X can represent a hydrogen atom, a C1-C3 alkoxy group, or a cyclopropylmethoxy group, and Y can be a hydrogen atom or a methoxy group. These compounds are deemed useful in the therapy of various medical conditions.

Career Highlights

Phillip Manoury has made significant strides at Synthelabo, a company renowned for its research in pharmaceutical development. His innovative work in the realm of therapeutics showcases his dedication to advancing health solutions through inventive chemistry.

Collaborations

Throughout his career, Manoury has collaborated with esteemed colleagues, including Daniel C. Obitz and Michel Peynot. These partnerships have fostered an environment of creativity and innovation, further enhancing the potential impact of their collective research efforts.

Conclusion

In summary, Phillip Manoury is an accomplished inventor whose work in developing new therapeutic compounds marks a significant contribution to the medical field. His patent reflects a commitment to innovation, and his collaborations highlight the importance of teamwork in advancing scientific understanding and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…